Sel Sanayi Urunleri Ticaret ve Pazarlama A.S.
The aim of this study is to evaluate the effectiveness of Hydrolyzed collagen peptides on joint pain, stiffness and physical function in adults with osteoarthritis who have complaints on knee joints together with hip and ankles. The assessment of improvements on volunteers' quality of life, and safety and tolerability of the product is the other objective of this placebo-controlled, randomized study.
Pain, Joint
Hydrolyzed Collagen Peptide
Not Applicable
Study Type : | Interventional |
Estimated Enrollment : | 160 participants |
Masking : | Quadruple |
Primary Purpose : | Supportive Care |
Official Title : | A Multiple-Dose, Randomized, Double-Blinded, Placebo Controlled Trial To Evaluate The Efficacy Of Hydrolyzed Collagen Peptide On Knees, Hips, and Ankle Pains In Adults With Osteoarthritis |
Actual Study Start Date : | May 15, 2022 |
Estimated Primary Completion Date : | May 15, 2023 |
Estimated Study Completion Date : | May 15, 2023 |
Arm | Intervention/treatment |
---|---|
Experimental: Hydrolyzed Collagen Peptide This arm will be allocated randomly and receive 10 g hydrolized collagen peptide (Investigational Product) daily throughout the study. |
Dietary Supplement: Hydrolyzed Collagen Peptide |
Placebo Comparator: Placebo This arm will be allocated randomly and receive placebo daily throughout the study. |
Dietary Supplement: Hydrolyzed Collagen Peptide |
Ages Eligible for Study: | 45 Years to 60 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.